Literature DB >> 24596541

Incorporating Complex Sample Design Effects When Only Final Survey Weights are Available.

Brady T West1, Sean Esteban McCabe2.   

Abstract

This article considers the situation that arises when a survey data producer has collected data from a sample with a complex design (possibly featuring stratification of the population, cluster sampling, and / or unequal probabilities of selection), and for various reasons only provides secondary analysts of those survey data with a final survey weight for each respondent and "average" design effects for survey estimates computed from the data. In general, these "average" design effects, presumably computed by the data producer in a way that fully accounts for all of the complex sampling features, already incorporate possible increases in sampling variance due to the use of the survey weights in estimation. The secondary analyst of the survey data who then 1) uses the provided information to compute weighted estimates, 2) computes design-based standard errors reflecting variance in the weights (using Taylor Series Linearization, for example), and 3) inflates the estimated variances using the "average" design effects provided is applying a "double" adjustment to the standard errors for the effect of weighting on the variance estimates, leading to overly conservative inferences. We propose a simple method for preventing this problem, and provide a Stata program for applying appropriate adjustments to variance estimates in this situation. We illustrate two applications of the method to survey data from the Monitoring the Future (MTF) study, and conclude with suggested directions for future research in this area.

Entities:  

Year:  2012        PMID: 24596541      PMCID: PMC3939068     

Source DB:  PubMed          Journal:  Stata J        ISSN: 1536-867X            Impact factor:   2.637


  6 in total

1.  Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males.

Authors:  P N Roset; M Farré; R de la Torre; M Mas; E Menoyo; C Hernández; J Camí
Journal:  Drug Alcohol Depend       Date:  2001-11-01       Impact factor: 4.492

2.  Complications of intranasal prescription narcotic abuse.

Authors:  Jason Yewell; Richard Haydon; Sanford Archer; Jose M Manaligod
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-02       Impact factor: 1.547

Review 3.  2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  William A Watson; Toby L Litovitz; Wendy Klein-Schwartz; George C Rodgers; Jessica Youniss; Nicole Reid; Wayne G Rouse; Rebecca S Rembert; Douglas Borys
Journal:  Am J Emerg Med       Date:  2004-09       Impact factor: 2.469

4.  Motives, diversion and routes of administration associated with nonmedical use of prescription opioids.

Authors:  Sean Esteban McCabe; James A Cranford; Carol J Boyd; Christian J Teter
Journal:  Addict Behav       Date:  2006-07-13       Impact factor: 3.913

5.  Palatal perforation associated with intranasal prescription narcotic abuse.

Authors:  Wendi M Jewers; Yeshwant B Rawal; Carl M Allen; John R Kalmar; Eric Fox; Guillermo E Chacon; Parish P Sedghizadeh
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2005-05

Review 6.  Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.

Authors:  Scott H Kollins
Journal:  J Clin Psychiatry       Date:  2003       Impact factor: 4.384

  6 in total
  12 in total

1.  Associations Between Early Onset of E-cigarette Use and Cigarette Smoking and Other Substance Use Among US Adolescents: A National Study.

Authors:  Sean Esteban McCabe; Brady T West; Vita V McCabe
Journal:  Nicotine Tob Res       Date:  2018-07-09       Impact factor: 4.244

2.  Leftover prescription opioids and nonmedical use among high school seniors: a multi-cohort national study.

Authors:  Sean Esteban McCabe; Brady T West; Carol J Boyd
Journal:  J Adolesc Health       Date:  2012-11-22       Impact factor: 5.012

3.  Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.

Authors:  Sean Esteban McCabe; Kara Dickinson; Brady T West; Timothy E Wilens
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-04-07       Impact factor: 8.829

4.  Trends in Medical and Nonmedical Use of Prescription Opioids Among US Adolescents: 1976-2015.

Authors:  Sean Esteban McCabe; Brady T West; Phil Veliz; Vita V McCabe; Sarah A Stoddard; Carol J Boyd
Journal:  Pediatrics       Date:  2017-03-20       Impact factor: 7.124

5.  Smoking behaviors and intentions among current e-cigarette users, cigarette smokers, and dual users: A national survey of U.S. high school seniors.

Authors:  Sean Esteban McCabe; Phil Veliz; Vita V McCabe; Carol J Boyd
Journal:  Prev Med       Date:  2017-03-01       Impact factor: 4.018

6.  Initiation Sequence of E-Cigarette and Cigarette Smoking among US Adolescents: A National Study.

Authors:  Sean Esteban McCabe; Philip Veliz; Vita V McCabe; Carol J Boyd
Journal:  Am J Addict       Date:  2019-04-16

7.  Medical and nonmedical use of prescription benzodiazepine anxiolytics among U.S. high school seniors.

Authors:  Sean Esteban McCabe; Brady T West
Journal:  Addict Behav       Date:  2014-01-28       Impact factor: 3.913

8.  Medical and nonmedical use of prescription stimulants: results from a national multicohort study.

Authors:  Sean Esteban McCabe; Brady T West
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-09-23       Impact factor: 8.829

9.  Prevalence and correlates of co-ingestion of prescription tranquilizers and other psychoactive substances by U.S. high school seniors: Results from a national survey.

Authors:  Ty S Schepis; Brady T West; Christian J Teter; Sean Esteban McCabe
Journal:  Addict Behav       Date:  2015-08-12       Impact factor: 3.913

10.  Adolescent athletic participation and nonmedical Adderall use: an exploratory analysis of a performance-enhancing drug.

Authors:  Philip Veliz; Carol Boyd; Sean Esteban McCabe
Journal:  J Stud Alcohol Drugs       Date:  2013-09       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.